2687-8941

JCO Global Oncology

American Society of Clinical Oncology

View prefix report (10.1200)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add license metadata to 1854 records

License metadata tells indexers and readers how each article may be reused.

High impact1854 DOIs
2

Attach ORCID iDs across 705 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact705 DOIs
3

Deposit reference lists for 501 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact501 DOIs

DOIs for this ISSN

Showing the top 5 of 1854 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis (10.1200/go.20.00097)
Abstract ORCID License
177.55 232
2 Cancer Statistics, 2020: Report From National Cancer Registr… (10.1200/go.20.00122)
ORCID License
149.43 973
3 Effect of Cancer on Clinical Outcomes of Patients With COVID… (10.1200/go.20.00225)
ORCID License
113.12 182
4 Bridging the Gap in Access to Care for Children With CNS Tum… (10.1200/go.20.00047)
Abstract ORCID License
110.78 29
5 Treatment of Patients With Late-Stage Colorectal Cancer: ASC… (10.1200/jgo.19.00367)
ORCID License
107.61 141
6 Lung Cancer Disparities in Hispanics: Molecular Diagnosis an… (10.1200/go.20.00004)
Abstract ORCID License
106.12 25
7 It Is Time to Close the Gap in Cancer Care (10.1200/go.22.00429)
Abstract ORCID License
104.85 24
8 Reduction in the Number of Procedures and Hospitalizations a… (10.1200/go.20.00471)
Abstract ORCID License
100.68 21
9 Telemedicine During the COVID-19 Pandemic: Impact on Care fo… (10.1200/go.20.00220)
ORCID License
98.42 92
10 Overview of Breast Cancer and Implications of Overtreatment… (10.1200/go.20.00033)
ORCID License
95.42 80
11 Reimagining Global Oncology Clinical Trials for the Postpand… (10.1200/go.20.00346)
Abstract ORCID License
94.15 17
12 ESMO/ASCO Recommendations for a Global Curriculum in Medical… (10.1200/go.23.00277)
References ORCID License
94.15 17
13 Breast Cancer Care in Jordan (10.1200/jgo.19.00279)
ORCID License
93.46 73
14 Global Partnerships for HPV Vaccine Must Look Beyond Nationa… (10.1200/go.20.00504)
Abstract ORCID License
92.28 16
15 Cancer and Indigenous Populations: Time to End the Disparity (10.1200/jgo.19.00379)
Abstract ORCID License
92.28 16
16 Meta-Analysis of Prevalence of Triple-Negative Breast Cancer… (10.1200/go.20.00054)
ORCID License
91.94 68
17 Overcoming Challenges in Providing Radiation Therapy to Pati… (10.1200/jgo.19.00177)
Abstract ORCID License
90.31 15
18 Role of Axillary Surgery After Neoadjuvant Chemotherapy (10.1200/jgo.19.00351)
Abstract ORCID License
90.31 15
19 Disparities in Cancer-Specific Survival Between Māori and No… (10.1200/go.20.00028)
ORCID License
89.97 62
20 Working Together to Build a Better Future for Children With… (10.1200/go.20.00170)
Abstract ORCID License
88.21 14
21 Radiotherapy Planning and Peer Review in Sub-Saharan Africa:… (10.1200/go.20.00188)
Abstract ORCID License
88.21 14
22 Population-Based Cancer Registration in Sub-Saharan Africa:… (10.1200/go.20.00294)
Abstract License
88.17 57
23 Oncofertility as a Universal Right and a Global Oncology Pri… (10.1200/go.19.00337)
Abstract ORCID License
85.96 13
24 Global Access to Radiotherapy—Work in Progress (10.1200/go.20.00562)
Abstract ORCID License
85.96 13
25 Predictors of Survival After Head and Neck Squamous Cell Car… (10.1200/go.20.00014)
ORCID License
85.38 50
26 Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervic… (10.1200/go.20.00079)
ORCID License
85.38 50
27 Patients With Cancer and COVID-19: A WhatsApp Messenger-Base… (10.1200/go.20.00118)
ORCID License
84.95 49
28 Can the Adoption of Hypofractionation Guidelines Expand Glob… (10.1200/jgo.19.00261)
ORCID License
84.51 48
29 Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated… (10.1200/go.20.00030)
ORCID License
83.14 45
30 Breast Cancer in Young Women Presents With More Aggressive P… (10.1200/jgo.19.00228)
ORCID License
83.14 45
31 Outcome of Oncology Patients Infected With Coronavirus (10.1200/go.20.00064)
ORCID License
82.17 43
32 Follow-Up Care for Breast and Colorectal Cancer Across the G… (10.1200/go.20.00180)
ORCID License
82.17 43
33 Determinants of COVID-19 Mortality in Patients With Cancer F… (10.1200/go.20.00444)
ORCID License
82.17 43
34 Dual Challenge of Cancer and COVID-19: Impact on Health Care… (10.1200/go.20.00227)
ORCID License
81.67 42
35 Cost Effectiveness of Trastuzumab for Management of Breast C… (10.1200/jgo.19.00293)
ORCID License
81.67 42
36 Expected Medium- and Long-Term Impact of the COVID-19 Outbre… (10.1200/go.20.00589)
ORCID License
81.16 41
37 Survey of Fertility Preservation Options Available to Patien… (10.1200/jgo.2016.008144)
ORCID License
81.16 41
38 Nexus of Cancer and Cardiovascular Disease for Australia’s F… (10.1200/jgo.19.00088)
Abstract ORCID License
80.94 11
39 Quadruple-Negative Breast Cancer: An Uneven Playing Field (10.1200/jgo.19.00366)
Abstract ORCID License
80.94 11
40 Assessment of Knowledge and Screening in Oral, Breast, and C… (10.1200/jgo.19.00257)
ORCID License
80.64 40
41 Communication in Cancer Care in Asia: A Narrative Review (10.1200/go.22.00266)
Abstract License
79.55 38
42 Mobile Technologies and Cervical Cancer Screening in Low- an… (10.1200/jgo.19.00201)
ORCID License
78.99 37
43 Recommendations for Advancing the Diagnosis and Management o… (10.1200/jgo.19.00170)
ORCID License
78.41 36
44 Patient Delay in Breast Cancer Diagnosis in Two Hospitals in… (10.1200/go.20.00034)
ORCID License
77.82 35
45 Five-Year Cancer Epidemiology at the National Referral Hospi… (10.1200/go.20.00155)
ORCID License
77.82 35
46 Qualitative Study of Pediatric Early Warning Systems’ Impact… (10.1200/go.20.00163)
ORCID License
77.82 35
47 State of Cancer Control in Rwanda: Past, Present, and Future… (10.1200/go.20.00281)
ORCID License
77.82 35
48 Survey of the Impact of COVID-19 on Oncologists’ Decision Ma… (10.1200/go.20.00300)
ORCID License
77.82 35
49 Perspective of Oncology Patients During COVID-19 Pandemic: A… (10.1200/go.20.00172)
ORCID License
77.20 34
50 Systematic Review of Modern Case Series of Squamous Cell Can… (10.1200/go.20.00094)
ORCID License
76.57 33